Allergen extract- and component-based diagnostics in children of the ALLIANCE asthma cohort

Chrysanthi Skevaki, Pavel Tafo, Kathrin Eiringhaus, Nina Timmesfeld, Markus Weckmann, Christine Happle, Philipp P Nelson, Nicole Maison, Bianca Schaub, Isabell Ricklefs, Oliver Fuchs, Erika von Mutius, Matthias Volkmar Kopp, Harald Renz, Gesine Hansen, Anna-Maria Dittrich, ALLIANCE Study Group, Chrysanthi Skevaki, Pavel Tafo, Kathrin Eiringhaus, Nina Timmesfeld, Markus Weckmann, Christine Happle, Philipp P Nelson, Nicole Maison, Bianca Schaub, Isabell Ricklefs, Oliver Fuchs, Erika von Mutius, Matthias Volkmar Kopp, Harald Renz, Gesine Hansen, Anna-Maria Dittrich, ALLIANCE Study Group

Abstract

Background: Current in vitro allergen-specific IgE (sIgE) detection assays measure IgE against allergen extracts or molecules in a single- or multiplex approach. Direct comparisons of the performance of such assays among young children with common presentations of allergic diseases regardless of sensitization status are largely missing.

Objectives: The aim of this study was a comparison of the analytical and diagnostic performance for common clinical questions of three commonly used technologies which rely upon different laboratory methodologies among children of the All Age Asthma (ALLIANCE) cohort (clinicaltrials.gov: NCT02496468).

Methods: Sera from 106 paediatric study participants (mean age 4 years) were assessed for the presence of sIgE by means of the ImmunoCAP™ sx1 and fx5 mixes, the ImmunoCAP ISAC™ 112 microarray and a Euroline™ panel.

Results: Total and negative concordance was high (>82%->89%), while positive concordance varied considerably (0%-100%) but was also >50% for the most common sensitizations analysed (house dust mite and birch). All three test systems showed good sensitivity and specificity (AUC consistently > 0.7). However, no significant differences with regard to identifying sIgE sensitizations associated with symptoms in children with suspected pollen- or dust-triggered wheeze or presenting with symptoms of allergic rhinoconjunctivitis or food allergy were detected. Extending the number of allergens did not change the similar performance of the three assay systems.

Conclusion and clinical relevance: Among young children, the three sIgE assays showed good analytical and diagnostic concordance. Our results caution that the identification of larger numbers of sensitizations by more comprehensive multiplex approaches may not improve the clinical utility of sIgE testing in this age group.

Keywords: allergen sIgE; analytical performance; diagnostic performance; in vitro allergy diagnosis; molecular allergology.

© 2021 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.

References

REFERENCES

    1. Hatzler L, Panetta V, Lau S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol. 2012;130(4):894-901.e5.
    1. Westman M, Lupinek C, Bousquet J, et al. Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol. 2015;135(5):1199-1206.e11.
    1. Dang TD, Peters RL, Koplin JJ, et al. Egg allergen specific IgE diversity predicts resolution of egg allergy in the population cohort HealthNuts. Allergy. 2019;74(2):318-326.
    1. Fontanella S, Frainay C, Murray CS, Simpson A, Custovic A. Machine learning to identify pairwise interactions between specific IgE antibodies and their association with asthma, A cross-sectional analysis within a population-based birth cohort. PLoS Med. 2018;15(11):e1002691.
    1. Asarnoj A, Hamsten C, Wadén K, et al. Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study. J Allergy Clin Immunol. 2016;137(3):813-21.e7.
    1. Posa D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017;139(2):541-549.e8.
    1. Konradsen JR, Nordlund B, Lidegran M, et al. Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy. Pediatr Allergy Immunol. 2011;22(1 Pt 1):9-18.
    1. Westman M, Åberg K, Apostolovic D, et al. Sensitization to grass pollen allergen molecules in a birth cohort-natural Phl p 4 as an early indicator of grass pollen allergy. J Allergy Clin Immunol. 2020;145(4):1174-1181.e6.
    1. Eiringhaus K, Renz H, Matricardi P, Skevaki C. Component-resolved diagnosis in allergic rhinitis and asthma. J Appl Lab Med. 2019;3(5):883-898.
    1. Steering Committee Authors and Review Panel Members. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@). Update 2020. World Allergy Organ J. 2020;13(2):100091.
    1. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, et al. EAACI Molecular Allergology User's Guide. Pediatr Allergy Immunol. 2016;27(Suppl 23):1-250.
    1. Fuchs O, Bahmer T, Weckmann M, et al. The all age asthma cohort (ALLIANCE) - from early beginnings to chronic disease: a longitudinal cohort study. BMC Pulm Med. 2018;18(1):140.
    1. Buzzulini F, Da Re M, Scala E, et al. Evaluation of a new multiplex assay for allergy diagnosis. Clin Chim Acta. 2019;493:73-78.
    1. Heffler E, Puggioni F, Peveri S, Montagni M, Canonica GW, Melioli G. Extended IgE profile based on an allergen macroarray, A novel tool for precision medicine in allergy diagnosis. World Allergy Organ J. 2018;11:7.
    1. Gadisseur R, Chapelle J-P, Cavalier E. A new tool in the field of in-vitro diagnosis of allergy, Preliminary results in the comparison of ImmunoCAP© 250 with the ImmunoCAP© ISAC. Clin Chem Lab Med. 2011;49(2):277-280.
    1. Melioli G, Bonifazi F, Bonini S, et al. The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin Biochem. 2011;44(12):1005-1011.
    1. Williams P, Önell A, Baldracchini F, Hui V, Jolles S, El-Shanawany T. Evaluation of a novel automated allergy microarray platform compared with three other allergy test methods. Clin Exp Immunol. 2016;184(1):1-10.
    1. Di Fraia M, Arasi S, Castelli S, et al. A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study. Clin Exp Allergy. 2019;49(3):341-349.
    1. Griffiths RLM, El-Shanawany T, Jolles SRA, et al. Comparison of the performance of skin prick, ImmunoCAP, and ISAC Tests in the diagnosis of patients with allergy. Int Arch Allergy Immunol. 2017;172(4):215-223.
    1. Wang J, Godbold JH, Sampson HA. Correlation of serum allergy (IgE) tests performed by different assay systems. J Allergy Clin Immunol. 2008;121(5):1219-1224.
    1. Lizaso MT, García BE, Tabar AI, et al. Comparison of conventional and component-resolved diagnostics by two different methods (Advia-Centaur/Microarray-ISAC) in pollen allergy. Ann Allergy Asthma Immunol. 2011;107(1):35-41.
    1. Ott H, Fölster-Holst R, Merk HF, Baron JM. Allergen microarrays: a novel tool for high-resolution IgE profiling in adults with atopic dermatitis. Eur J Dermatol. 2010;20(1):54-61.
    1. Önell A, Whiteman A, Nordlund B, et al. Allergy testing in children with persistent asthma: comparison of four diagnostic methods. Allergy. 2017;72(4):590-597.
    1. Käck U, Asarnoj A, Grönlund H, et al. Molecular allergy diagnostics refine characterization of children sensitized to dog dander. J Allergy Clin Immunol. 2018;142(4):1113-1120.e9.
    1. Heaps A, Carter S, Selwood C, et al. The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis. Clin Exp Immunol. 2014;177(2):483-490.
    1. Luengo O, Labrador M, Guilarte M, Garriga T, Sala A, Cardona V. Structured assessment of component resolved diagnosis using a immunoassay platform for multiplex measurement of sIgE in multi-sensitised allergic patients, Late Breaking Poster Sessions. Allergy. 2010;65(s92):694-756.
    1. Passalacqua G, Melioli G, Bonifazi F, et al. The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. Allergy. 2013;68(8):1029-1033.
    1. Sastre J, Landivar ME, Ruiz-García M, Andregnette-Rosigno MV, Mahillo I. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy. 2012;67(5):709-711.
    1. Letrán A, Espinazo M, Moreno F. Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy. Ann Allergy Asthma Immunol. 2013;111(4):295-297.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera